CapsoVision (CV) Receivables (2025 - 2026)

CapsoVision (CV) posted Receivables of $1.9 million for Q3 2025, up 0.86% sequentially from $1.9 million in Q2 2025.

CapsoVision (CV) Receivables (2025 - 2026) Analysis & Trends

CapsoVision has reported Receivables for 1 years, with the latest figure at $1.9 million in Q3 2025.

Quarterly Receivables changed N/A year-over-year to $1.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.9 million (changed N/A YoY) and the FY2025 annual result came in at $2.5 million, up 24.84% from the prior year.
Receivables rose to $1.9 million in Q3 2025 per CV's latest filing, from $1.9 million in the prior quarter.
Over five years, Receivables peaked at $1.9 million in Q3 2025 and troughed at $1.9 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	8.60 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	3.74 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	6.64 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	3.18 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	955.70 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	1.28 Bn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	4.66 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	4.12 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	1.01 Bn
10	CapsoVision	295.13 Mn	286.05 Mn	1.87 Mn	2.27 Mn

Download Data